Discover
CGEM
Cullinan Therapeutics, Inc.
21.08
2 x 15.12
2 x 26.52
bid
ask
-
0.28
1.31%
2 @ 04:08 AM
21.21 +0.13 (0.62%)
| Ytd | 103.67% | |
| 1y | 232.49% |
20.63
day range
21.45
5.68
52 week range
23.19
| Open | 21.36 | Prev Close | 21.36 | Low | 20.63 | High | 21.45 | Mkt Cap | 1.36B |
| Vol | 3.25M | Avg Vol | 828.42K | EPS | -3.11 | P/E | N/A | Forward P/E | -7.90 |
| Beta | 0.02 | Short Ratio | 14.92 | Inst. Own | 112.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-14 | 50-d Avg | 19.64 | 200-d Avg | 15.10 | 1yr Est | 33.55 |
| Income Statement | |||
| Operating Expenses | 57.25M | ||
| Research and Development Expense | 44.44M | ||
| Selling, General and Administrative Expense | 12.82M | ||
| Operating Income | -57.25M | ||
| Net Income | -53.70M | ||
| Net Income Common Stock | -53.70M | ||
| Net Income Common Stock (USD) | -53.70M | ||
| Consolidated Income | -53.70M | ||
| Earnings per Basic Share | -0.81 | ||
| Earnings per Basic Share (USD) | -0.81 | ||
| Earnings per Diluted Share | -0.81 | ||
| Earning Before Interest & Taxes (EBIT) | -53.70M | ||
| Earning Before Interest & Taxes (USD) | -53.70M | ||
| Preferred Dividends Income Statement Impact | 487.10K | ||
| Weighted Average Shares | 61.49M | ||
| Weighted Average Shares Diluted | 61.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 78.64M | ||
| Cash and Equivalents (USD) | 78.64M | ||
| Investments | 274.92M | ||
| Investments Current | 255.90M | ||
| Investments Non-Current | 19.02M | ||
| Current Assets | 341.97M | ||
| Property, Plant & Equipment Net | 2.50M | ||
| Total Assets | 363.79M | ||
| Debt Current | 666.00K | ||
| Total Debt | 2.07M | ||
| Current Liabilities | 40.63M | ||
| Debt Non-Current | 1.41M | ||
| Total Liabilities | 42.03M | ||
| Accumulated Retained Earnings (Deficit) | -691.48M | ||
| Accumulated Other Comprehensive Income | -134.00K | ||
| Shareholders Equity | 321.75M | ||
| Shareholders Equity (USD) | 321.75M | ||
| Assets Non-Current | 21.81M | ||
| Total Debt (USD) | 2.07M | ||
| Liabilities Non-Current | 1.41M | ||
| Trade and Non-Trade Payables | 3.73M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 79.00K | ||
| Net Cash Flow from Financing | 1.10M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.56M | ||
| Issuance (Purchase) of Equity Shares | 1.10M | ||
| Net Cash Flow from Investing | 40.68M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 40.68M | ||
| Net Cash Flow from Operations | -38.22M | ||
| Share Based Compensation | 8.45M | ||